SKI Market

Indian Indices

Nifty

25,875.80 180.85
(0.70%)

Sensex

84,743.15 276.64
( 0.33%)

Bank Nifty

58,274.65 136.50
( 0.23%)

Nifty IT

36,855.40 738.50
( 2.04%)

Global Indices

Nasdaq

48,279.16 330.20
(0.69%)

Dow Jones

6,872.70 5.09
(0.07%)

Hang Seng

51,039.34 196.41
(0.39%)

Nikkei 225

9,910.49 10.89
(0.11%)

Forex

USD-INR

88.68 0.06
(0.07%)

EUR-INR

102.52 0.03
(0.03%)

GBP-INR

116.74 0.13
(0.11%)

JPY-INR

0.58 0.00
(-0.30%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Coral Laboratories Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

524506

INE683E01017

563.5943978

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

10.04

185.34

EPS(TTM)

Face Value()

Div & Yield %

51.72

Back

Kapil Raj Finance standalone net profit rises 357.14% in the September 2025 quarter

Oct 17,2025

Net profit of Kapil Raj Finance rose 357.14% to Rs 0.32 crore in the quarter ended September 2025 as against Rs 0.07 crore during the previous quarter ended September 2024. Sales reported to Rs 0.30 crore in the quarter ended September 2025. There were no Sales reported during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	0.30	0	0
OPM %	73.33	0	-
PBDT	0.32	0.07	357
PBT	0.32	0.07	357
NP	0.32	0.07	357

25,875.80 180.85 (0.70%)

84,743.15 276.64 ( 0.33%)

58,274.65 136.50 ( 0.23%)

36,855.40 738.50 ( 2.04%)

48,279.16 330.20 (0.69%)

6,872.70 5.09 (0.07%)

51,039.34 196.41 (0.39%)

9,910.49 10.89 (0.11%)

88.68 0.06 (0.07%)

102.52 0.03 (0.03%)

116.74 0.13 (0.11%)

0.58 0.00 (-0.30%)